Role played by peritoneal dialysis in treating refractory heart failure;Papel de la diálisis peritoneal en el tratamiento de la insuficiencia cardiaca refractaria

Nefrologia

Volumn 30, Issue 1, 2010, Pages 21-27

  Montejo, J D ^a   Rubio, M Auxiliadora Bajo ^a   Del Peso, G ^a   Selgas, R ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Icodextrin; Peritoneal dialysis; Refractory heart failure

Indexed keywords

HEART FAILURE; HUMAN; PERITONEAL DIALYSIS; REVIEW;

HEART FAILURE; HUMANS; PERITONEAL DIALYSIS;

EID: 77449096074     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2010.Jan.10204     Document Type: Article

References (47)

1. Khalifeh N, Vychytil A, Hörl WH. The role of peritoneal dialysis in the management of treatment-resistant congestive heart failure: A European prospective. Kidney Int 2006;70:S72-S75.
2. Krisham A, Oreopulos D. Peritoneal dialysis in congestive heart failure. Advances in Peritoneal Dialysis 2007;23:82-9.
3. Vasan R, Wilson P. Epidemiology and causes of heart failure. Up To Date 16.3.
4. Dickstein K, Cohen-Solal A, Filippatos G, et al. Treatment of acute and chronic Heart failure 2008. Eur Heart J 2008;29:2388-42.
5. Crespo M, Paniagua M. Tratamiento de la insuficiencia cardiaca refractaria o avanzada. Rev Esp Cardiol 2004;57:869-83.
6. Mehrotra R, Kathuria P. Place of peritoneal dialysis in the management of treatment-resistant congestive heart failure. Kidney Int 2006;70:S67-S71.
7. Kagan A, Rapoport J. The role of peritoneal dialysis in the treatment of refractory heart failure. Nephrol Dial Transplant 2005;(Suppl 7):S28-S31.
8. Rubinger D. Management of refractory congestive heart failure-a nephrological challenge. Nephrol Dial Transplant 2005;(Suppl 7):S37-S40.
9. Arora N, Dellsperger K. Heart failure and dialysis: New thoughts and trends. Advances in Peritoneal Dialysis 2007;23:72-5.
10. Silverberg D, Wexler K, Blum M, et al. The association between congestive heart failure and chronic renal disease. Curr Opin Nephrol Hypertens 2004;13:163-70.
11. Gotlieb SS, Abraham W, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Cardiol Failure 2002;8:136-41.
12. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. Circulation 2001;104:2996-3007.
13. Klein L, O'Connor CM, et al. Lower serum sodium is associated with increased short term mortality in hospitalized patients with worsening Heart failure: results from the Outcomes of a prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (Optime-CHF) study. Circulation 2005;111:2454-60.
14. Gheorgiade M, Gattis WA, et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized control trial. JAMA 2004;291:1963-71.
15. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-18.
16. Gil P, Justo S, Castilla M, et al. Cardio-renal insufficiency: the search for management strategies. Curr Opin Nephrol Hypertens 2005;14:442-7.
17. Ellison D. Diuretic therapy and resistance in congestive heart failure. Cardiology 2001;96:132-43.
18. Domansky M, Norman J, Pitt B, et al. Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 2003;42:705-8.
19. De Goma E, Vagelos R, Fowler M, et al. Emerging therapies for the management of descompensated heart failure. J Am Coll Cardiol 2006;48:2397.
20. Kazory A, Ross E. Contemporary trends in the pharmacological and extracorporeal management of heart failure: A Nephrologic perspective. Circulation 2008;117:975-83.
21. Gheorgiade M, Konstam M, Burnett J, et al. Short term clinical effects of tolvaptan, an oral vasopressin antagonist in patients hospitalized for heart failure. The Everest clinical status trials. JAMA 2007;297:1332-43.
22. Constanzo MR, Saltzberg M, O'Sullivan J, et al. Early ultrafiltration in patients with descompensated heart failure and diuretic resistance. J Am Coll Cardiol 2005;46:2047-51.
23. Kazory A, Ejaz A, Ross E. Ultrafiltration for heart failure: How fast should we move? Am Heart J 2009;157:205-7.
24. Costanzo MR, Saltzberg M, et al. Early ultrafiltration in patients with descompensated heart failure and diuretic resistance. J Am Coll Cardiol 2005;46:2047-51.
25. Libetta C, Sepe V, Zucchi M, et al. Intermittent haemodiafiltration in refractory NP and balance of inflammatory cytokines. Nephrol Dial Transplant 2007;22:2013-9.
26. Bourge RC, Tallaj JA. Ultrafiltration: a new approach toward mechanical diuresis in heart failure. J Am Coll Cardiol 2005;46:2052-3.
27. Costanzo MR, Guglin M, Saltzberg M, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute descompensated heart failure. J Am Coll Cardiol 2007;49:675-83.
28. Zemel D, Imholz AL, De Waart DR, et al. Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int 1994;46:1422-30.
29. Schneierson SJ. Continuous peritoneal irrigation in the treatment of intractable edema of cardiac origin. Am J Med Sci 1949;218:76-9.
30. Mailloux LU, Swartz CD, Onesti G, et al. Peritoneal dialysis for refractory congestive heart failure. JAMA 1967;199:873-8.
31. Shapira J, Lang R, Jutrin I, et al. Peritoneal dialysis in refractory congestive heart failure. Part I: intermittent peritoneal dialysis (IPD). Perit Dial Bull 1983;3:130-1.
32. Bart BA, Boyle A, Bank AJ, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the relief for acutely fluid overloaded patients with decompensated congestive heart failure (RAPID-CHF) trial. J Am Coll Cardiol 2005;46:2043-6.
33. Rubin J, Ball R. Continuous ambulatory peritoneal dialysis as treatment of severe congestive heart failure in the face of chronic renal failure. Report of eight cases. Arch Intern Med 1986;146:1533-5.
34. Robson M, Biro A, Knobel B, et al. Peritoneal dialysis in refractory congestive Heart failure part II: continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Bull 1983; 3: 133-134, 1983
35. Kim D, Khanna R, Wu G, et al. Succesful use of continuous ambulatory peritoneal dialysis in refractory heart failure. Perit Dial Bull 1985;5:127-30.
36. Mc Kinnie JJ, Bourgeois RJ, Hosserl FE. Long-term therapy for heart failure with continuous ambulatory peritoneal dialysis. Arch Intern Med 1985;145:1128-9.
37. Konig PS, Lhotta K, Kronenberg F, et al. CAPD: A successful treatment in patients suffering from therapy resistant congestive heart failure. Adv Perit Dial 1991;7:97-101.
38. Stegmayr BG, Banga R, Lundberg L, et al. PD treatment for severe congestive heart failure. Perit Dial Int 1996;16(Suppl 1):S231-S235.
39. Ryckelynck JP, Lobbedez T, Valette B, et al. Peritoneal ultrafiltration and treatment-resistant heart failure. Nephrol Dial Transplant 1998;13(Suppl 4): 56-9.
40. Elhalel-Dranitsky M, Rubinger D, Moscovici A, et al. CAPD to improve quality of life in patients with refractory heart failure. Nephrol Dial Transplant 1998;13:3041-2.
41. Kagan A, Rapoport J. The role of peritoneal dialysis in the treatment of refractory heart failure: Nephrol Dial Transplant 2005;20(Suppl 7):S28-S31.
42. Gotloib L, Fudin R, Yakubovich M, et al. Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation. Nephrol Dial Transplant 2005;20(Suppl. 7):S28-S31.
43. Ryckelynck JP, Lobbedez T, Valette B, et al. Peritoneal ultrafiltration and refractory congestive heart failure. Adv Perit Dial 1997;13:93-7.
44. Bertoli SV, Ciurlino D, Maccario M, et al. Home peritoneal ultrafiltration in patients with severe congestive HeART failure without end stage renal disease. Adv Perit Dial 2005;21:123-7.
45. Díez B, Suárez C, Vidau P, et al. Papel de la diálisis peritoneal en el tratamiento de la insuficiencia cardiaca. Experiencia en nuestro centro. Nefrologia 2007;27:605-11.
46. Basile C, Chimienti D, Bruno A, et al. Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure. Perit Dial Int 2009;29:116-8.
47. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation 2005;112:e154-e235.